These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

429 related items for PubMed ID: 15139476

  • 1. Self-administered, standardized regimens for multidrug-resistant tuberculosis in South Korea.
    Park SK, Lee WC, Lee DH, Mitnick CD, Han L, Seung KJ.
    Int J Tuberc Lung Dis; 2004 Mar; 8(3):361-8. PubMed ID: 15139476
    [Abstract] [Full Text] [Related]

  • 2. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W, Nagayama N, Miyamoto M, Hara H, Suzuki J, Masuda K, Baba M, Tamura A, Nagai H, Akagawa S, Kawabe Y, Machida K, Kurashima A, Yotsumoto H.
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [Abstract] [Full Text] [Related]

  • 3. [Analysis of causes of drug resistance and therapeutic effects on 27 multi-drug resistant pulmonary tuberculosis patients].
    Ye Z, Pei X, Yang Y.
    Zhonghua Jie He He Hu Xi Za Zhi; 1997 Aug; 20(4):234-6. PubMed ID: 10072811
    [Abstract] [Full Text] [Related]

  • 4. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK, Kim JH, Kang H, Cho JS, Smego RA.
    Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
    [Abstract] [Full Text] [Related]

  • 5. Outcome of chemotherapy in 107 patients with pulmonary tuberculosis resistant to isoniazid and rifampin.
    Park SK, Kim CT, Song SD.
    Int J Tuberc Lung Dis; 1998 Nov; 2(11):877-84. PubMed ID: 9848607
    [Abstract] [Full Text] [Related]

  • 6. Ambulatory treatment of multidrug-resistant pulmonary tuberculosis patients at a chest clinic.
    Kim HJ, Hong YP, Kim SJ, Lew WJ, Lee EG.
    Int J Tuberc Lung Dis; 2001 Dec; 5(12):1129-36. PubMed ID: 11769771
    [Abstract] [Full Text] [Related]

  • 7. Pharmacokinetics of prothionamide in patients with multidrug-resistant tuberculosis.
    Lee HW, Kim DW, Park JH, Kim SD, Lim MS, Phapale PB, Kim EH, Park SK, Yoon YR.
    Int J Tuberc Lung Dis; 2009 Sep; 13(9):1161-6. PubMed ID: 19723408
    [Abstract] [Full Text] [Related]

  • 8. Frequency of recurrence among MDR-tB cases 'successfully' treated with standardised short-course chemotherapy.
    Migliori GB, Espinal M, Danilova ID, Punga VV, Grzemska M, Raviglione MC.
    Int J Tuberc Lung Dis; 2002 Oct; 6(10):858-64. PubMed ID: 12365571
    [Abstract] [Full Text] [Related]

  • 9. [Treatment outcome of patients with multidrug-resistant pulmonary tuberculosis during pregnancy].
    Takashima T, Danno K, Tamura Y, Nagai T, Matsumoto T, Han Y, Ano H, Yoshida H, Kawahara K, Tsuyuguchi I.
    Kekkaku; 2006 Jun; 81(6):413-8. PubMed ID: 16838679
    [Abstract] [Full Text] [Related]

  • 10. Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Kwon YS, Kim YH, Suh GY, Chung MP, Kim H, Kwon OJ, Choi YS, Kim K, Kim J, Shim YM, Koh WJ.
    Clin Infect Dis; 2008 Aug 15; 47(4):496-502. PubMed ID: 18611154
    [Abstract] [Full Text] [Related]

  • 11. Using treatment failure under effective directly observed short-course chemotherapy programs to identify patients with multidrug-resistant tuberculosis.
    Becerra MC, Freeman J, Bayona J, Shin SS, Kim JY, Furin JJ, Werner B, Sloutsky A, Timperi R, Wilson ME, Pagano M, Farmer PE.
    Int J Tuberc Lung Dis; 2000 Feb 15; 4(2):108-14. PubMed ID: 10694087
    [Abstract] [Full Text] [Related]

  • 12. [Treatment outcomes of multidrug-resistant tuberculosis--comparison between success and failure cases].
    Shigetoh E, Murakami I, Yokosaki Y, Kurimoto N.
    Kekkaku; 2001 Dec 15; 76(12):723-8. PubMed ID: 11806128
    [Abstract] [Full Text] [Related]

  • 13. Revised Category II regimen as an alternative strategy for retreatment of Category I regimen failure and irregular treatment cases.
    Tabarsi P, Chitsaz E, Tabatabaei V, Baghaei P, Shamaei M, Farnia P, Marjani M, Kazempour M, Mansouri D, Masjedi MR, Velayati AA.
    Am J Ther; 2011 Sep 15; 18(5):343-9. PubMed ID: 20535008
    [Abstract] [Full Text] [Related]

  • 14. Treatment of multiple drug-resistant tuberculosis (MDR-TB) in Iran.
    Mirsaeidi SM, Tabarsi P, Khoshnood K, Pooramiri MV, Rowhani-Rahbar A, Mansoori SD, Masjedi H, Zahirifard S, Mohammadi F, Farnia P, Masjedi MR, Velayati AA.
    Int J Infect Dis; 2005 Nov 15; 9(6):317-22. PubMed ID: 16183321
    [Abstract] [Full Text] [Related]

  • 15. Impact of extensive drug resistance on treatment outcomes in non-HIV-infected patients with multidrug-resistant tuberculosis.
    Kim HR, Hwang SS, Kim HJ, Lee SM, Yoo CG, Kim YW, Han SK, Shim YS, Yim JJ.
    Clin Infect Dis; 2007 Nov 15; 45(10):1290-5. PubMed ID: 17968823
    [Abstract] [Full Text] [Related]

  • 16. Multidrug-resistant tuberculosis at Srinagarind Hospital, Khon Kaen, Thailand.
    Reechaipichitkul W.
    Southeast Asian J Trop Med Public Health; 2002 Sep 15; 33(3):570-4. PubMed ID: 12693593
    [Abstract] [Full Text] [Related]

  • 17. Impact of extensively drug-resistant tuberculosis on treatment outcome of multidrug-resistant tuberculosis patients with standardized regimen: report from Iran.
    Tabarsi P, Chitsaz E, Baghaei P, Shamaei M, Farnia P, Marjani M, Kazempour M, Amiri M, Mansouri D, Masjedi MR, Velayati AA, Caminero JA.
    Microb Drug Resist; 2010 Mar 15; 16(1):81-6. PubMed ID: 20192820
    [Abstract] [Full Text] [Related]

  • 18. [The short-term and long-term treatment outcomes in patients with pulmonary tuberculosis positive for drug-resistant and sensitive strains].
    Han JP, Sun SL, Li RZ, Zhang FS, Wang SC, Cheng J, Deng YF, Wang Y, Yu CB.
    Zhonghua Jie He He Hu Xi Za Zhi; 2003 Feb 15; 26(2):70-3. PubMed ID: 12783654
    [Abstract] [Full Text] [Related]

  • 19. Results of a 12-month regimen for drug-resistant pulmonary tuberculosis.
    Pérez-Guzmán C, Vargas MH, Martínez-Rossier LA, Torres-Cruz A, Villarreal-Velarde H.
    Int J Tuberc Lung Dis; 2002 Dec 15; 6(12):1102-9. PubMed ID: 12546119
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and safety of kanamycin, ethionamide, PAS and cycloserine in multidrug-resistant pulmonary tuberculosis patients.
    Prasad R, Verma SK, Sahai S, Kumar S, Jain A.
    Indian J Chest Dis Allied Sci; 2006 Dec 15; 48(3):183-6. PubMed ID: 18610675
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.